Full history for every metric is available with a Kvantra account
Intelicanna Ltd (INTL.TA)
Key financial summary
Financials in PEN| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | ||
|---|---|---|---|---|---|---|---|
| Total revenue | PEN m | 3,539 | 3,508 | 3,815 | 2,060 | 3,277 | 4,066 |
| Operating profit | PEN m | 1,824 | |||||
| Net profit | PEN m | 1,263 | 1,181 | 1,287 | 96 | 899 | 1,217 |
| EPS reported | PEN | 15.28 | |||||
| Operating cashflow per share | PEN | -3.59 | |||||
| Capex per share | PEN | 0.64 | |||||
| FCF per share | PEN | -4.22 | |||||
| Free cash flow | PEN m | -337 | |||||
| Net debt | PEN m | -2,026 | |||||
| Book value equity | PEN m | 7,617 | |||||
| Book value per share | PEN | 95.57 | |||||
| Number of shares | m | 79.7 | |||||
| DPS (TTM paid) | PEN | 3.94 |
Financial summary
Financials in PEN| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | ||
|---|---|---|---|---|---|---|---|
| Value | |||||||
| P/E TTM | x | - | |||||
| P/B LTM | x | 0.00 | |||||
| P/S LTM | x | 0.00 | |||||
| P/FCF LTM | x | -0.01 | |||||
| EV/EBITDA LTM | x | -24.30 | |||||
| EV/Sales LTM | x | -0.50 | |||||
| Earnings Yield LTM | % | 44275.7% | |||||
| FCF Yield | % | -12245.4% | |||||
| Quality | |||||||
| ROE | % | 15.98% | |||||
| ROIC | % | 46.67% | |||||
| Operating margin | % | 44.85% | |||||
| Gross margin | % | 100.00% | |||||
| FCF/Sales | % | -8.28% | |||||
| Growth and momentum | |||||||
| EPS Growth YoY | % | +35.46% | |||||
| Sales Growth YoY | % | +24.09% | |||||
| Net Income Growth YoY | % | +35.49% | |||||
| FCF Growth | % | - | |||||
| Operating Profit Growth | % | +33.48% | |||||
| Dividend and capital structure | |||||||
| Dividend Yield | % | 11433.5% | |||||
| Dividend Growth | % | - | |||||
| Payout Ratio | % | 25.82% | |||||
| FCF/Debt | x | - | |||||
| Net Debt/EBITDA | x | -24.33 | |||||
| EBIT/Net interest | x | 0.00 | |||||
| Net debt/market cap | % | -73698.8% | |||||
| Net debt/Equity | x | -0.27 | |||||
| Gross debt/equity | x | 0.00 | |||||
Company overview
Intelicanna Ltd operates as an Israeli pharmaceutical company. It specializes in the complete lifecycle of medical cannabis, encompassing cultivation, production, research, marketing, and sales of its therapeutic products. Founded in 1981, the firm was formerly known as Tefen Industrial Engineering & Management & Systems Analysis until it rebranded as Intelicanna Ltd in March 2019. Its corporate headquarters are situated in Hod Hasharon, Israel.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Intelicanna Ltd (INTL.TA)
Intelicanna Ltd operates as an Israeli pharmaceutical company. It specializes in the complete lifecycle of medical cannabis, encompassing cultivation, production, research, marketing, and sales of its therapeutic products. Founded in 1981, the firm was formerly known as Tefen Industrial Engineering & Management & Systems Analysis until it rebranded as Intelicanna Ltd in March 2019. Its corporate headquarters are situated in Hod Hasharon, Israel.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free